Plain language summary of the TRANSFORM study primary analysis results: liso-cell as a second treatment regimen for large B-cell lymphoma following failure of the first treatment regimen
Future Oncology | March 28, 2024 | Volume: 20 | Issue: 21 | Pages: 1455-1465
10.2217/fon-2023-0898
| PMID 38547003